
Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14
Published: Dec. 11, 2024
Glabridin, a flavonoid derived from the plant
Language: Английский
Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14
Published: Dec. 11, 2024
Glabridin, a flavonoid derived from the plant
Language: Английский
International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125293 - 125293
Published: Jan. 1, 2025
Language: Английский
Citations
0Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 381, P. 113615 - 113615
Published: March 12, 2025
Glioblastoma (GB) is a malignant brain tumor with low survival rates and high recurrence ratio due to limited therapeutic arsenal. The repurposed drug disulfiram (DSF), approved for alcoholism treatment, shows promising anticancer antimicrobial activity, but its poor biopharmaceutical profile hinders clinical use. This work aimed develop DSF-loaded silk fibroin (SF) electrospun fibers controlled release in the postsurgical resection cavity. Incorporating hydroxypropyl-β-cyclodextrin (HPβCD), which formed inclusion complexes DSF, enhanced rate activity (>3 logCFUs reduction) against Staphylococcus aureus Pseudomonas aeruginosa. Addition of CuCl2 enabled situ formation Cu(DDC)2 complexes, further boosting vitro antitumoral effects nanofibers (≤ 500 nm) while maintaining adequate mechanical properties. Selective toxicity DSF glioblastoma cells, sparing astrocytes, highlights potential targeted cancer therapy. Increased potency at concentrations when combined SF fibers, HPβCD copper was remarkable. Thus, delivery bioavailability can be significantly optimized through nanofibers, may also allow more precise dosing. Combination radiotherapy explored assess translational as part combination therapy regimen glioblastoma. In vivo studies rat model simulating GB surgery confirmed safety selected formulations healthy tissue. However, findings suggest that alone insufficient complete eradication, indicating need existing therapies target residual cells effectively.
Language: Английский
Citations
0Frontiers in Oncology, Journal Year: 2025, Volume and Issue: 15
Published: March 14, 2025
The research and development of new anti-cancer drugs face challenges such as high costs, lengthy cycles, limited data on side effects. In contrast, the clinical safety effects traditional have been well established through long-term use. or repurposing with potential applications in cancer treatment offers an economical, feasible, promising strategy for drug development. This article reviews novel tumor immunotherapy, discussing how they can enhance efficacy functional repositioning, while also reducing time costs. Recent advancements immunotherapy revolutionized options, but resistance to ICIs remains a significant challenge. Drug has emerged identify agents that immunotherapies by overcoming ICI resistance. A study suggests repositioning modulate immune cell activity alter microenvironment, thereby circumventing mechanisms associated checkpoint blockade. approach provides rapid cost-effective pathway identifying therapeutic candidates be quickly transitioned into trials. To improve effectiveness it is crucial explore systematic methods repurposed candidates. Methods high-throughput screening, computational bioinformatic analysis employed efficiently treatment. Furthermore, leveraging databases related provide valuable resources discovery facilitate identification compounds. It focuses latest use antidiabetic drugs, antihypertensive agents, weight-loss medications, antifungal antiviral examining their action, application prospects, challenges. this context, our aim these strategies highlight expanding options available providing references
Language: Английский
Citations
0Journal of Molecular Structure, Journal Year: 2025, Volume and Issue: unknown, P. 142077 - 142077
Published: March 1, 2025
Language: Английский
Citations
0Structural Chemistry, Journal Year: 2025, Volume and Issue: unknown
Published: March 28, 2025
Language: Английский
Citations
0Microchemical Journal, Journal Year: 2025, Volume and Issue: unknown, P. 113672 - 113672
Published: April 1, 2025
Language: Английский
Citations
0Journal of Molecular Liquids, Journal Year: 2024, Volume and Issue: 415, P. 126409 - 126409
Published: Nov. 7, 2024
Language: Английский
Citations
0Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14
Published: Dec. 11, 2024
Glabridin, a flavonoid derived from the plant
Language: Английский
Citations
0